|
|
PVCT Provectus Biopharmaceuticals
|
|
||
Re: developing immune activators to target hard-to-treat solid tumors The cost of cancer treatments could become increasingly scrutinized if a Democrat wins the presidency and Congress lowers the Medicare age as a step toward more universal coverage. |
return to message board, top of board |